Diabetic foot ulcers (DFUs) present a major clinical challenge in India, where chronic hyperglycemia often leads to severely impaired wound healing. Consequently, conventional diabetic foot ulcer therapy frequently struggles to address complex pathology involving oxidative stress and chronic inflammation. Researchers are now focusing on mesenchymal stem cells (MSCs) to bridge this gap in regenerative care. However, traditional cell-based therapies face significant hurdles like poor cell survival and high immunogenicity. Therefore, the scientific community is shifting its attention toward MSC-derived exosomes, which act as powerful paracrine mediators. These nano-sized vesicles carry bioactive proteins and microRNAs that promote angiogenesis and tissue regeneration effectively.

Innovating Diabetic Foot Ulcer Therapy with Injectable Hydrogels

Notably, delivering these exosomes directly to the wound site requires advanced biomaterial platforms. Injectable hydrogels serve as biomimetic scaffolds that mimic the natural extracellular matrix. Furthermore, these hydrogels protect exosomes from rapid degradation in the harsh wound environment. They enable a sustained and localized release of therapeutic cargo, which significantly improves clinical outcomes. Specifically, these systems address multiple barriers simultaneously by reducing inflammation and enhancing vascularization. Moreover, emerging smart hydrogels can respond to physiological triggers like pH changes or glucose levels. As a result, these next-generation platforms offer a highly personalized approach to diabetic foot ulcer therapy. Ultimately, combining exosomes with hydrogel technology represents a breakthrough in regenerative medicine.

Frequently Asked Questions

Why are exosomes preferred over whole stem cells for DFU treatment?

Exosomes offer lower immunogenicity and better stability than whole cells. Additionally, they carry specific bioactive molecules that direct tissue repair without the risks of cell rejection or tumor formation associated with live cell transplants.

How do hydrogels benefit the wound healing process?

Hydrogels provide a moist environment and structural support for the wound bed. Furthermore, they act as a controlled-release system that keeps therapeutic agents at the site for longer durations, reducing the frequency of dressing changes.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional recommendation. Refer to the latest local and national guidelines for clinical practice.

References

Sadrzadeh SA et al. Advanced regenerative solutions in diabetic foot ulcer therapy: delivery of mesenchymal stem cells in injectable hydrogels. Stem Cell Res Ther. 2026 Apr 27. doi: 10.1186/s13287-026-05036-y. PMID: 42045987.

Wang J, Liang YJ, Pan X. Advances in the Role of Stem Cell-Derived Exosomes in Diabetic Foot Wound Healing. Diabetes Metab Syndr Obes. 2025;18:2767-2781. doi: 10.2147/DMSO.S521095.

International Working Group on the Diabetic Foot (IWGDF). Guidelines on interventions to enhance healing of foot ulcers in people with diabetes. IWGDF 2023 Update.